On Air Now

Current Show

The Mike McFeely Show   2:00 PM - 5:00 PM

Call the KFGO Studio at (701) 237-5948 or (800) 880-5346. Email us at kfgo.studio@kfgo.com or text us at short code 35270.

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 790 AM Fargo-Moorhead

Weather

Current Conditions(Fargo,ND 58103)

More Weather »
73° Feels Like: 73°
Wind: WNW 15 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Mostly Sunny 82°

Tonight

Partly Cloudy 58°

Tomorrow

PM Thunderstorms 73°

Alerts

Sanofi trial shows Fluzone high-dose flu vaccine efficacy

PARIS (Reuters) - Sanofi said on Monday that a large clinical trial showed its Fluzone High-Dose vaccine to be more effective at preventing influenza in adults aged 65 and older than a standard dose of Fluzone.

Sanofi said it plans to submit the full clinical study report to the U.S. Food and Drug Administration for review by early 2014 and will seek to modify to the label for Fluzone High-Dose vaccine to reflect the superior efficacy data in this age group.

In the study, which included roughly 30,000 participants, Fluzone High-Dose vaccine was 24.2 percent more effective in preventing influenza in adults 65 years of age and older than Fluzone vaccine.

Fluzone High-Dose vaccine was licensed for sale by the FDA in 2009 under an accelerated approval process that included a requirement that Sanofi complete a large-scale confirmatory study.

(Reporting by Leila Abboud)

Comments